OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genome-wide CRISPR/Cas9 screening for drug resistance in tumors
Zhongyan Zhang, Hailiang Wang, Qian Yan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Zhongyan Zhang, Hailiang Wang, Qian Yan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Showing 6 citing articles:
DTX2 attenuates Lenvatinib-induced ferroptosis by suppressing docosahexaenoic acid biosynthesis through HSD17B4-dependent peroxisomal β-oxidation in hepatocellular carcinoma
Zhongyan Zhang, Qi Zhou, Zhenchong Li, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101224-101224
Closed Access | Times Cited: 2
Zhongyan Zhang, Qi Zhou, Zhenchong Li, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101224-101224
Closed Access | Times Cited: 2
Advancing personalized medicine: Integrating statistical algorithms with omics and nano-omics for enhanced diagnostic accuracy and treatment efficacy
Abdurrahman Coşkun, Gökhan Ertaylan, Murih Pusparum, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 7, pp. 167339-167339
Closed Access | Times Cited: 7
Abdurrahman Coşkun, Gökhan Ertaylan, Murih Pusparum, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 7, pp. 167339-167339
Closed Access | Times Cited: 7
Applications of single-cell technologies in drug discovery for tumor treatment
Bingyu Liu, Shunfeng Hu, Xin Wang
iScience (2024) Vol. 27, Iss. 8, pp. 110486-110486
Closed Access | Times Cited: 5
Bingyu Liu, Shunfeng Hu, Xin Wang
iScience (2024) Vol. 27, Iss. 8, pp. 110486-110486
Closed Access | Times Cited: 5
CRISPR/Cas technologies for cancer drug discovery and treatment
Kevin Chang Wang, Thomas M Zheng, Basil P. Hubbard
Trends in Pharmacological Sciences (2025)
Closed Access
Kevin Chang Wang, Thomas M Zheng, Basil P. Hubbard
Trends in Pharmacological Sciences (2025)
Closed Access
Loss of the aryl hydrocarbon receptor promotes cancer cell resistance to BRAFV600E targeted therapies
Mourad Zerfaoui, Dharmeshkumar Patel, Yueqi Zhang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Mourad Zerfaoui, Dharmeshkumar Patel, Yueqi Zhang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
YAP1 Inhibitors Enhance the Therapeutic Effect of Gemcitabine on PDCA by Inhibiting MSLN Expression, EMT, and Pancreatic Fibrosis
Jili Hu, Xu Guo, Wang Jia, et al.
(2025)
Closed Access
Jili Hu, Xu Guo, Wang Jia, et al.
(2025)
Closed Access
Exploring Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-Associated Protein 9 (CRISPR-Cas9) as a Therapeutic Modality for Cancer: A Scoping Review
Abirami Balasubramanian, Keerthana Veluswami, Sudipta Rao, et al.
Cureus (2024)
Open Access
Abirami Balasubramanian, Keerthana Veluswami, Sudipta Rao, et al.
Cureus (2024)
Open Access
Leveraging Circular Polymerization and Extension Cloning (CPEC) Method for Construction of CRISPR Screening Libraries
Bengisu Dayanc, Sude Eris, Şerif Şentürk
BIO-PROTOCOL (2024) Vol. 15, Iss. 1365
Open Access
Bengisu Dayanc, Sude Eris, Şerif Şentürk
BIO-PROTOCOL (2024) Vol. 15, Iss. 1365
Open Access
